Pharmacological Management of Resistant Hypertension in Moderate-to-advanced CKD: A Glance at Novel Non-steroidal MRAs

Curr Pharm Des. 2023;29(26):2033-2035. doi: 10.2174/1381612829666230825103201.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Heart Failure*
  • Humans
  • Hypertension* / drug therapy
  • Renal Insufficiency, Chronic* / drug therapy
  • Spironolactone

Substances

  • Spironolactone